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he Elderly Are
ot So Old Anymore*
. Vernon Anderson, MD, FACC,†
ichard G. Bach, MD, FACC‡
ouston, Texas; and St. Louis, Missouri
When I am old and greyheaded, O God, forsake me not
Psalms 71:18
ne of the greatest challenges in clinical medical practice is
ltering it as new information becomes available. The
onstant drive to understand and then apply new material is
n overwhelming task, especially in cardiovascular diseases,
nd far beyond the capacity of any single individual today.
he amount of data (“data” in all its varieties and forms)
hat must be evaluated, reviewed, interpreted, adjusted,
einterpreted, and then carried forward into planned
hanged behavior require the talents of many individuals all
orking together (1). This difficulty is in fact just the
ationale for forming clinical practice guidelines groups, an
See page 1479
ctivity that constitutes one of the very best purposes of
rofessional societies such as the American College of
ardiology (ACC) and the American Heart Association
AHA). To be sure, guidelines themselves are only sugges-
ions for how to approach certain clinical problems and
ituations. They do not, fortunately, have the force of law,
or should they. No guideline could ever encompass all of
he nuances and singularities that make individual clinical
ases unique. However, individual cases can be sufficiently
imilar enough so that guidelines (i.e., organized sugges-
ions) are worthwhile. And periodic updating of guidelines
y professional groups is a necessary and desirable way of
ommunicating to everyone a thoughtful analysis of accumu-
ated evidence and a plan for moving it into practice (2,3).
Several very important lessons about this have been
earned during the past few years (1–7). First, observers have
oted that variations in care exist between geographic areas
r between clinical specialties for the same or similar
onditions. Second, adoption of evidence-based guidelines
ecommendations tends to reduce variations in care toward
common approach. Third, reducing variations by using
uidelines usually results in better outcomes, that is, lower
ortality and/or fewer adverse events. Finally, it has been
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Cardiology Division, University of Texas Health Science Center,s
ouston, Texas; and ‡Cardiovascular Division, Washington University Medical
enter, St. Louis, Missouri.bserved that adoption of guidelines to reduce care varia-
ions is not a uniform process either but itself seems to be
uite haphazard. One group for which the adoption of
uidelines recommendations has been slow and inconsistent
s the elderly. The most commonly expressed theme for this
esitancy to make changes has seemed to be the perceived
risk” associated with treatments applied to an elderly
opulation. Too often the dictum of primum non nocere wins
ut. If a treatment (drug or procedure) used in an elderly
erson might be associated with risk, for example, if
dministering a platelet-inhibiting agent like clopidogrel in
n acute coronary syndrome might be associated with some
ncreased risk of bleeding, then perhaps it is better not to use
hat treatment. However, what is lost in this syllogism is the
act that in many cases the elderly are at increased risk from
he underlying disease too, more so than younger patients,
nd therefore the potential benefit of a treatment also might
e greater for them. Somehow, this possibility of saving
ore lives or reducing disabilities gets lost or overlooked.
he acute coronary syndromes problem. Every year in
his country there are upwards of 5.3 million emergency room
isits for chest pain syndromes, with at least 1.4 million
ospital admissions for unstable angina (UA) and non–ST-
egment elevation myocardial infarction (NSTEMI). In 2002,
n ACC/AHA clinical guidelines committee published up-
ated evidence-based recommendations for the treatment of
A/NSTEMI. These recommendations were followed shortly
y an initiative to help track implementation of these guide-
ines, the Can rapid risk stratification of unstable angina
atients suppress adverse outcomes with early implementation
f the ACC/AHA guidelines (CRUSADE) initiative (8).
he guidelines recommendations are not complex or diffi-
ult, amounting to evaluation of the patient for the use of
ertain medications (aspirin, clopidogrel, beta-blockers,
eparin or low molecular weight heparin, and platelet
lycoprotein IIb/IIIa inhibitors) and one procedure (cardiac
atheterization within 48 h). The suggested strategy has
ven been reduced to convenient algorithms (9). What is
ow emerging from CRUSADE and other large scale
nalyses of clinical practice is the finding that these guide-
ines recommendations are not being implemented widely,
nd the group most shortchanged is the elderly. Just
ecently, a large international registry of patients with acute
oronary syndromes (both STEMI and NSTEMI), i.e., the
RACE registry, reported significantly decreased use of
uidelines recommended therapies in the elderly. (10) And
ow in this issue of the Journal, the CRUSADE registry
11) reports similar findings in much larger numbers.
pportunity gaps. One of the important things that the
RUSADE group has done in this study was examine for
ontraindications. Not unexpectedly, contraindications to
our of the guidelines medications did increase with increas-
ng age. But although this trend was clearly evident, the
ctual numbers of patients with contraindications were
urprisingly (and gratifyingly) low. More importantly, even
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October 18, 2005:1488–9 Editorial Commenthen adjusted for any contraindications, recommended
herapy was still given much less often in the elderly
ompared with the non-elderly. This gap must be reduced.
nother hugely important finding from this study in addi-
ion to the medications was the observation that the elderly
ad early invasive management used in dishearteningly low
ates. It’s likely that some clustering of treatment patterns
xists here because an earlier CRUSADE report noted that
here was a correlation between early invasive management
nd appropriate use of guidelines recommended medica-
ions (12). That is, places in which patients were more likely
o receive recommended medications also were places in
hich patients were more likely to get early invasive
anagement. Work that we have done as part of the
hrombolysis In Myocardial Ischemia (TIMI) study group
as helped highlight the importance of an early invasive
anagement approach in UA/NSTEMI, an approach that
s most especially promising in elderly patients (13). Data
rom the Fragmin and Fast Revascularization During In-
tability in Coronary Artery Disease Trial (FRISC) II and
andomized Intervention Trial of unstable Angina
RITA)-3 also support it (14,15). As Alexander et al. (11)
oint out, increasing the use of an early invasive strategy
ay be one of the biggest opportunities for improving
utcomes for elderly patients with NSTEMI.
onclusions. We need to invert the current equation so
hat instead of calculating a “risk score” for acute coronary
yndromes, we should instead calculate an “opportunity
core.” The opportunity score would give an estimate of the
enefit to be gained by a treatment or group of treatments.
atients with higher baseline risks from the underlying
isease, such as the elderly, would have higher opportunity
cores for benefit, even allowing for some of the greater risks
rom the treatment. Perhaps if we approached it this way,
ot as “risk” but as “opportunity,” we might then feel more
omfortable about using the guideline-recommended ther-
pies. We must listen to the psalmist’s lament, and we too
ust not forsake the elderly what is known to be beneficial.
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